TY  - JOUR

T1  - Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.

JO  - Clinical Cancer Research

UR  - http://eprints.whiterose.ac.uk/110818/

PY  - 2014/06/01

AU  - Ottewell PD

AU  - Wang N

AU  - Brown HK

AU  - Reeves KJ

AU  - Fowles CA

AU  - Croucher PI

AU  - Eaton CL

AU  - Holen I

ED  - 

DO  - DOI: 10.1158/1078-0432.CCR-13-1246

VL  - 20

IS  - 11

SP  - 2922

EP  - 2932

Y2  - 2024/10/23

ER  -